Author(s):
Madhuri Sanjay Wable, Samruddhi Subhash Adsul, Jaydeep Babasaheb Pawar
Email(s):
madhuriwable7@gmail.com
DOI:
10.52711/2231-5659.2026.00027 
Address:
Madhuri Sanjay Wable, Samruddhi Subhash Adsul, Jaydeep Babasaheb Pawar
Shantiniketan College of Pharamcy, Dhotre B.K., Parner, Ahilyanagar, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 2,
Year - 2026
ABSTRACT:
The review highlights the versatility of preparation methods, particularly the solvent-casting production process, and novel 3D printing techniques that bring inherent flexibility. Three-dimensional printing technology not only diversifies active compounds but also enables a multilayer approach, effectively segregating incompatible drugs. For local and/or systemic drug delivery, Oro-dispersible films (ODFs) are thin, flexible, mechanically robust polymeric films that dissolve or disintegrate quickly in the oral cavity. Numerous facets of ODFs and their potential as a drug delivery system are examined in this review. Recent developments are briefed, including the thorough investigation of formulation ingredients like polymers and plasticizers. In addition to allowing for a multilayer approach and diversifying active ingredients, three-dimensional printing technology efficiently separates incompatible medications. An important advancement that increases the effectiveness of oral drug administration and expands the range of medications that can be administered through this route is the use of nanoparticles into ODF formulations. This review offers a thorough overview of the changing field of Oro dispersible drug delivery by illuminating the many in vitro evaluation techniques used to describe ODFs, ongoing clinical trials, approved commercial goods, and recent patents. Present-day patient-centric strategies include creating ODFs with features that are more patient-friendly, like better taste masking, simpler administration, and increased patient compliance, as well as tailoring ODF formulations to each patient's requirements. For quick advancement in the developing field of Oro-dispersible drug administration, it is essential to investigate new functional excipients that may improve the penetration of oligonucleotides, fragile proteins, and high-molecular-weight polar pharmaceuticals.
Cite this article:
Madhuri Sanjay Wable, Samruddhi Subhash Adsul, Jaydeep Babasaheb Pawar. Emerging Trends in ODF Formulation. Asian Journal of Research in Pharmaceutical Sciences.2026; 16(2):172-0. doi: 10.52711/2231-5659.2026.00027
Cite(Electronic):
Madhuri Sanjay Wable, Samruddhi Subhash Adsul, Jaydeep Babasaheb Pawar. Emerging Trends in ODF Formulation. Asian Journal of Research in Pharmaceutical Sciences.2026; 16(2):172-0. doi: 10.52711/2231-5659.2026.00027 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2026-16-2-12
REFERENCE:
1. Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. Advances in oral drug delivery. Frontiers in pharmacology. 2021 Feb 19; 12:618411.
2. Bhattacharyya N. The prevalence of dysphagia among adults in the United States. Otolaryngology--Head and Neck Surgery. 2014 Nov; 151(5):765-9.
3. Hearnden V, Sankar V, Hull K, Juras DV, Greenberg M, Kerr AR, Lockhart PB, Patton LL, Porter S, Thornhill MH. New developments and opportunities in oral mucosal drug delivery for local and systemic disease. Advanced drug delivery reviews. 2012 Jan 1; 64(1):16-28.
4. Ghourichay MP, Kiaie SH, Nokhodchi A, Javadzadeh Y. Formulation and quality control of orally disintegrating tablets (ODTs): recent advances and perspectives. BioMed Research International. 2021; 2021(1):6618934.
5. Hoffmann EM, Breitenbach A, Breitkreutz J. Advances in orodispersible films for drug delivery. Expert opinion on drug delivery. 2011 Mar 1; 8(3):299-316.
6. Samineni R, Chimakurthy J, Konidala S. Emerging role of biopharmaceutical classification and biopharmaceutical drug disposition system in dosage form development: A systematic review. Turkish journal of pharmaceutical sciences. 2022 Dec 21; 19(6):706.
7. Cazón A, Morer P, Matey L. PolyJet technology for product prototyping: Tensile strength and surface roughness properties. Proceedings of the Institution of Mechanical Engineers, Part B: Journal of Engineering Manufacture. 2014 Dec; 228(12):1664-75.
8. Visser JC, Woerdenbag HJ, Crediet S, Gerrits E, Lesschen MA, Hinrichs WL, Breitkreutz J, Frijlink HW. Orodispersible films in individualized pharmacotherapy: The development of a formulation for pharmacy preparations. International journal of pharmaceutics. 2015 Jan 15; 478(1):155-63.
9. Lee Y, Kim K, Kim M, Choi DH, Jeong SH. Orally disintegrating films focusing on formulation, manufacturing process, and characterization. Journal of Pharmaceutical Investigation. 2017 May; 47(3):183-201.
10. Al-Khattawi A, Mohammed AR. Compressed orally disintegrating tablets: excipients evolution and formulation strategies. Expert opinion on drug delivery. 2013 May 1; 10(5):651-63.
11. Van der Merwe J, Steenekamp J, Steyn D, Hamman J. The role of functional excipients in solid oral dosage forms to overcome poor drug dissolution and bioavailability. Pharmaceutics. 2020 Apr 25; 12(5):393.
12. Kesisoglou F, Wu Y. Understanding the effect of API properties on bioavailability through absorption modeling. The AAPS journal. 2008 Dec; 10(4):516-25.
13. Islam N, Irfan M, Zahoor AF, Iqbal MS, Syed HK, Khan IU, Rasul A, Khan SU, Alqahtani AM, Ikram M, Abdul Qayyum M. Improved bioavailability of ebastine through development of transfersomal oral films. Pharmaceutics. 2021 Aug 23; 13(8):1315.
14. Schiele JT, Quinzler R, Klimm HD, Pruszydlo MG, Haefeli WE. Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms. European journal of clinical pharmacology. 2013 Apr; 69(4):937-48.
15. Palo M, Holländer J, Suominen J, Yliruusi J, Sandler N. 3D printed drug delivery devices: perspectives and technical challenges. Expert review of medical devices. 2017 Sep 2; 14(9):685-96.
16. Charoo NA, Abdallah DB, Ahmed DT, Abrahamsson B, Cristofoletti R, Langguth P, Mehta M, Parr A, Polli JE, Shah VP, Kambayashi A. Biowaiver monograph for immediate-release solid oral dosage forms: levocetirizine dihydrochloride. Journal of pharmaceutical sciences. 2023 Apr 1; 112(4):893-903.
17. Zhang H, Zhang J, Streisand JB. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clinical pharmacokinetics. 2002 Aug; 41(9):661-80.
18. Cilurzo F, Musazzi UM, Franzé S, Selmin F, Minghetti P. Orodispersible dosage forms: Biopharmaceutical improvements and regulatory requirements. Drug discovery today. 2018 Feb 1; 23(2):251-9.
19. Patel S, Kaushal AM, Bansal AK. Compression physics in the formulation development of tablets. Critical Reviews™ in therapeutic drug carrier systems. 2006; 23(1).
20. Ghourichay MP, Kiaie SH, Nokhodchi A, Javadzadeh Y. Formulation and quality control of orally disintegrating tablets (ODTs): recent advances and perspectives. BioMed Research International. 2021; 2021(1):6618934.
21. Nyoni AB, Brook D. Wicking mechanisms in yarns—the key to fabric wicking performance. Journal of the Textile Institute. 2006 Mar 1; 97(2):119-28.
22. Berardi A, Bisharat L, Quodbach J, Rahim SA, Perinelli DR, Cespi M. Advancing the understanding of the tablet disintegration phenomenon–An update on recent studies. International Journal of Pharmaceutics. 2021 Apr 1; 598:120390.
23. Rizwan M, Yahya R, Hassan A, Yar M, Azzahari AD, Selvanathan V, Sonsudin F, Abouloula CN. pH sensitive hydrogels in drug delivery: Brief history, properties, swelling, and release mechanism, material selection and applications. Polymers. 2017 Apr 12; 9(4):137.
24. Pabari RM, Ramtoola Z. Effect of a disintegration mechanism on wetting, water absorption, and disintegration time of orodispersible tablets. Journal of young pharmacists. 2012 Jul 1; 4(3):157-63.
25. Mattsson S. Pharmaceutical binders and their function in directly compressed tablets: Mechanistic studies on the effect of dry binders on mechanical strength, pore structure and disintegration of tablets (Doctoral dissertation, Acta Universitatis Upsaliensis).
26. Wang J, Wen H, Desai D. Lubrication in tablet formulations. European journal of pharmaceutics and biopharmaceutics. 2010 May 1; 75(1):1-5.
27. Al-Khattawi A, Mohammed AR. Compressed orally disintegrating tablets: excipients evolution and formulation strategies. Expert opinion on drug delivery. 2013 May 1; 10(5):651-63.
28. Armstrong NA. Tablet manufacture by direct compression. Encyclopedia Pharmaceut Technol. 2007; 6:3673-83.
29. Vadaga AK, Gudla SS, Nareboina GS, Gubbala H, Golla B. Comprehensive review on modern techniques of granulation in pharmaceutical solid dosage forms. Intelligent Pharmacy. 2024 Oct 1; 2(5):609-29.
30. De Villiers MM. Oral conventional solid dosage forms: powders and granules, tablets, lozenges, and capsules. InTheory and Practice of Contemporary Pharmaceutics 2021 Feb 25 (pp. 279-331). CRC press.
31. Miller RW. Roller compaction technology. Drugs and the pharmaceutical sciences. 1997 Jun 17; 81:99-150.
32. Cantor SL, Augsburger LL, Hoag SW, Gerhardt A. Pharmaceutical granulation processes, mechanism, and the use of binders. InPharmaceutical Dosage Forms-Tablets 2008 Jun 3 (pp. 277-318). CRC Press.
33. Ghourichay MP, Kiaie SH, Nokhodchi A, Javadzadeh Y. Formulation and quality control of orally disintegrating tablets (ODTs): recent advances and perspectives. BioMed Research International. 2021; 2021(1):6618934.
34. Saharan VA. Current advances in drug delivery through fast dissolving/disintegrating dosage forms. Sharjah, United Arab Emirates: Bentham Science Publishers; 2017 May 11.
35. Luo Y, Hong Y, Shen L, Wu F, Lin X. Multifunctional role of polyvinylpyrrolidone in pharmaceutical formulations. AAPS PharmSciTech. 2021 Jan 6; 22(1):34.
36. Parkash V, Maan S, Yadav SK, Jogpal V. Fast disintegrating tablets: Opportunity in drug delivery system. Journal of advanced pharmaceutical technology & research. 2011 Oct 1; 2(4):223-35.
37. Deepak S, Dinesh K, Mankaran S, Gurmeet S, Rathore MS. Fast disintegrating tablets: a new era in novel drug delivery system and new market opportunities. J Drug Deliv Ther. 2012; 2(3):74-86.
38. Bácskay I, Arany P, Fehér P, Józsa L, Vasvári G, Nemes D, Pető Á, Kósa D, Haimhoffer Á, Ujhelyi Z, Sinka D. Bioavailability Enhancement and Formulation Technologies of Oral Mucosal Dosage Forms: A Review. Pharmaceutics. 2025 Jan 22; 17(2):148.
39. Li P, Zhao L. Developing early formulations: practice and perspective. International Journal of Pharmaceutics. 2007 Aug 16; 341(1-2):1-9.
40. Ghourichay MP, Kiaie SH, Nokhodchi A, Javadzadeh Y. Formulation and quality control of orally disintegrating tablets (ODTs): recent advances and perspectives. BioMed Research International. 2021; 2021(1):6618934.
41. Olea López AL, Johnson L. Associations between restrained eating and the size and frequency of overall intake, meal, snack and drink occasions in the UK adult national diet and nutrition survey. PLoS One. 2016 May 26; 11(5):e0156320.
42. Chandramouli M, Shivalingappa RP, Basavanna V, Doddamani S, Shanthakumar DC, Nagarajaiah SR, Ningaiah S. Oral thin-films from design to delivery: a pharmaceutical viewpoint. Biointerface Res Appl Chem. 2022 Mar 30; 13(2):177-0.
43. Olechno K, Basa A, Winnicka K. “Success depends on your backbone”—About the use of polymers as essential materials forming orodispersible films. Materials. 2021 Aug 27; 14(17):4872.
44. Sabir A, Altaf F, Shafiq M. Synthesis and characterization and application of chitin and chitosan-based eco-friendly polymer composites. InSustainable polymer composites and nanocomposites 2019 Feb 2 (pp. 1365-1405). Cham: Springer International Publishing.
45. Lisitsyn A, Semenova A, Nasonova V, Polishchuk E, Revutskaya N, Kozyrev I, Kotenkova E. Approaches in animal proteins and natural polysaccharides application for food packaging: Edible film production and quality estimation. Polymers. 2021 May 15; 13(10):1592.
46. Singh RS, Saini GK, Kennedy JF. Pullulan: microbial sources, production and applications. Carbohydrate polymers. 2008 Sep 5; 73(4):515-31.
47. Pezik E, Gulsun T, Sahin S, Vural I. Development and characterization of pullulan-based orally disintegrating films containing amlodipine besylate. European Journal of Pharmaceutical Sciences. 2021 Jan 1; 156:105597.